Drug interactions
Cenobamate + Dexamethasone-tobramycin
Severity: Moderate
Cenobamate and Dexamethasone-tobramycin: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Cenobamate is a CYP3A4 inducer and may reduce dexamethasone concentrations, weakening its anti-inflammatory effect. The impact is more important with systemic dexamethasone than with ophthalmic use.
What this interaction means in plain words
Cenobamate and Dexamethasone-tobramycin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Cenobamate belongs to Central Nervous System; Dexamethasone-tobramycin belongs to Anti Bacterial.
Why it happens
Cenobamate induces CYP3A4, increasing dexamethasone metabolism.
What to do
Monitor clinical response to dexamethasone and increase the dose if systemic therapy is ineffective.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Cenobamate and Dexamethasone-tobramycin, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Dexamethasone-tobramycin
Other interactions of Cenobamate
Frequently asked questions
Can I take Cenobamate with Dexamethasone-tobramycin?
MediHelp rates the interaction as moderate. Cenobamate and Dexamethasone-tobramycin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Cenobamate is a CYP3A4 inducer and may reduce dexamethasone concentrations, weakening its anti-inflammatory effect. The impact is more important with systemic dexamethasone than with ophthalmic use.
How serious is the interaction between Cenobamate and Dexamethasone-tobramycin?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor clinical response to dexamethasone and increase the dose if systemic therapy is ineffective.
What other medicines interact with Dexamethasone-tobramycin?
MediHelp also lists interactions of Dexamethasone-tobramycin with, for example, Capreomycin, Carboplatin, Ciprofloxacin. The full list is on the Dexamethasone-tobramycin page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
